Cisplatin Concentrations in Long and Short Duration Infusion: Implications for the Optimal Time of Radiation Delivery
Author(s) -
Pradeep Rajkumar,
Binu Mathew,
Saikat Das,
Rajesh Isaiah,
Subashini John,
Ratna Prabha,
Denise H. Fleming
Publication year - 2016
Publication title -
journal of clinical and diagnostic research
Language(s) - English
Resource type - Journals
eISSN - 2249-782X
pISSN - 0973-709X
DOI - 10.7860/jcdr/2016/18181.8126
Subject(s) - cisplatin , medicine , radiation therapy , pharmacokinetics , anesthesia , chemotherapy , sensitization , intravenous infusions , continuous infusion , urology , pharmacology , immunology
Cisplatin has radiosensitizing properties and the best sensitization to radiotherapy occurs with a higher plasma concentration of cisplatin. To our knowledge the optimal time sequence between chemotherapy and administration of radiation therapy, to obtain maximum effect from concurrent chemoradiation is unclear.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom